Summary by Futu AI
Tempus AI announced preliminary results for Q4 and full year 2025, achieving total revenue of $1.27 billion, representing 83% YoY growth with 30% organic growth excluding Ambry. Diagnostics revenue reached $955 million, up 111% YoY, driven by Oncology and Hereditary volume growth of 26% and 29% respectively. Data and applications revenue grew 31% YoY to $316 million.Q4 2025 revenue reached $367 million, up 83% YoY, with diagnostics revenue of $266 million growing 121% YoY. Data and applications revenue hit $100 million in Q4, up 25% YoY, with Insights segment growing 68% excluding the AstraZeneca warrant impact from Q4 2024.CEO Eric Lefkofsky highlighted 2025 as an exceptional year, with accelerating growth in both main business lines. The company enters 2026 in a strong position, leveraging AI across all products. Final audited results will be reported in February 2026.
